Switch to: Citations

Add references

You must login to add references.
  1. Why continuing uncertainties are no reason to postpone challenge trials for coronavirus vaccines.Robert Steel, Lara Buchak & Nir Eyal - 2020 - Journal of Medical Ethics 46 (12):808-812.
    To counter the pandemic caused by severe acute respiratory syndrome coronavirus 2, some have proposed accelerating SARS-CoV-2 vaccine development through controlled human infection trials. These trials would involve the deliberate exposure of relatively few young, healthy volunteers to SARS-CoV-2. We defend this proposal against the charge that there is still too much uncertainty surrounding the risks of COVID-19 to responsibly run such a trial.
    Download  
     
    Export citation  
     
    Bookmark   6 citations  
  • COVID-19 controlled human infection studies: worries about local community impact and demands for local engagement.Kyungdo Lee & Nir Eyal - 2021 - Journal of Medical Ethics 47 (8):539-542.
    In spring, summer and autumn 2020, one abiding argument against controlled human infection studies of SARS-CoV-2 vaccines has been their impact on local communities. Leading scientists and bioethicists expressed concern about undue usage of local residents’ direly needed scarce resources at a time of great need and even about their unintended infection. They recommended either avoiding CHI trials or engaging local communities before conducting any CHIs. Similar recommendations were not made for the alternative—standard phase III field trials of these same (...)
    Download  
     
    Export citation  
     
    Bookmark   4 citations